{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Microtechnologie : Questions médicales les plus fréquentes",
"headline": "Microtechnologie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Microtechnologie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-29",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Microtechnologie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Miniaturisation",
"url": "https://questionsmedicales.fr/mesh/D008904",
"about": {
"@type": "MedicalCondition",
"name": "Miniaturisation",
"code": {
"@type": "MedicalCode",
"code": "D008904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.897.520"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Microfluidique",
"alternateName": "Microfluidics",
"url": "https://questionsmedicales.fr/mesh/D044085",
"about": {
"@type": "MedicalCondition",
"name": "Microfluidique",
"code": {
"@type": "MedicalCode",
"code": "D044085",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.897.520.500.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Microtechnologie",
"alternateName": "Microtechnology",
"code": {
"@type": "MedicalCode",
"code": "D055616",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michael H Cole",
"url": "https://questionsmedicales.fr/author/Michael%20H%20Cole",
"affiliation": {
"@type": "Organization",
"name": "School of Behavioural and Health Sciences, Australian Catholic University, Brisbane, QL, 4014, Australia."
}
},
{
"@type": "Person",
"name": "Rich D Johnston",
"url": "https://questionsmedicales.fr/author/Rich%20D%20Johnston",
"affiliation": {
"@type": "Organization",
"name": "School of Behavioural and Health Sciences, Australian Catholic University, Brisbane, QL, 4014, Australia."
}
},
{
"@type": "Person",
"name": "Grant Duthie",
"url": "https://questionsmedicales.fr/author/Grant%20Duthie",
"affiliation": {
"@type": "Organization",
"name": "School of Behavioural and Health Sciences, Australian Catholic University, Strathfield, Australia."
}
},
{
"@type": "Person",
"name": "Adam Hewitt",
"url": "https://questionsmedicales.fr/author/Adam%20Hewitt",
"affiliation": {
"@type": "Organization",
"name": "School of Behavioural and Health Sciences, Australian Catholic University, Brisbane, QL, 4014, Australia."
}
},
{
"@type": "Person",
"name": "Seung Yeon Lee",
"url": "https://questionsmedicales.fr/author/Seung%20Yeon%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Engineering, Hongik University, Seoul 04066, South Korea."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.",
"datePublished": "2023-04-11",
"url": "https://questionsmedicales.fr/article/37065697",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.15125"
}
},
{
"@type": "ScholarlyArticle",
"name": "Relationship between the complement system and serum lipid profile in patients with rheumatoid arthritis.",
"datePublished": "2024-07-12",
"url": "https://questionsmedicales.fr/article/39072319",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1420292"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis.",
"datePublished": "2024-07-08",
"url": "https://questionsmedicales.fr/article/38978073",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13075-024-03360-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Contribution of Complement Protein C1q in COVID-19 and HIV Infection Comorbid with Preeclampsia: A Review.",
"datePublished": "2022-06-03",
"url": "https://questionsmedicales.fr/article/35661665",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000524976"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37286573",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-023-38383-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Technologie",
"item": "https://questionsmedicales.fr/mesh/D013672"
},
{
"@type": "ListItem",
"position": 4,
"name": "Miniaturisation",
"item": "https://questionsmedicales.fr/mesh/D008904"
},
{
"@type": "ListItem",
"position": 5,
"name": "Microtechnologie",
"item": "https://questionsmedicales.fr/mesh/D055616"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Microtechnologie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Microtechnologie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Microtechnologie",
"description": "Comment la microtechnologie aide-t-elle au diagnostic médical ?\nQuels dispositifs microtechnologiques sont utilisés pour le diagnostic ?\nLa microtechnologie peut-elle détecter des maladies précocement ?\nQuels avantages la microtechnologie offre-t-elle en diagnostic ?\nLa microtechnologie est-elle utilisée pour le diagnostic génétique ?",
"url": "https://questionsmedicales.fr/mesh/D055616?mesh_terms=Complement+System+Proteins&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Microtechnologie",
"description": "Quels symptômes peuvent être détectés par microtechnologie ?\nLa microtechnologie peut-elle identifier des symptômes précoces ?\nQuels types de symptômes sont surveillés par des dispositifs microtechnologiques ?\nLes symptômes peuvent-ils être quantifiés par microtechnologie ?\nLa microtechnologie aide-t-elle à surveiller les symptômes en temps réel ?",
"url": "https://questionsmedicales.fr/mesh/D055616?mesh_terms=Complement+System+Proteins&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Microtechnologie",
"description": "Comment la microtechnologie contribue-t-elle à la prévention des maladies ?\nQuels outils de microtechnologie sont utilisés pour la prévention ?\nLa microtechnologie aide-t-elle à la vaccination ?\nQuels avantages la microtechnologie offre-t-elle en prévention ?\nLa microtechnologie peut-elle aider à la gestion des épidémies ?",
"url": "https://questionsmedicales.fr/mesh/D055616?mesh_terms=Complement+System+Proteins&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Microtechnologie",
"description": "Comment la microtechnologie améliore-t-elle les traitements médicaux ?\nQuels traitements utilisent la microtechnologie ?\nLa microtechnologie est-elle utilisée en chirurgie ?\nQuels dispositifs microtechnologiques sont utilisés pour les traitements ?\nLa microtechnologie peut-elle améliorer la réhabilitation ?",
"url": "https://questionsmedicales.fr/mesh/D055616?mesh_terms=Complement+System+Proteins&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Microtechnologie",
"description": "Quelles complications peuvent survenir avec des dispositifs microtechnologiques ?\nComment minimiser les complications liées à la microtechnologie ?\nLes complications sont-elles fréquentes avec la microtechnologie ?\nQuels types de complications peuvent affecter les implants microtechnologiques ?\nLa microtechnologie peut-elle causer des complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D055616?mesh_terms=Complement+System+Proteins&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Microtechnologie",
"description": "Quels facteurs de risque sont associés à l'utilisation de la microtechnologie ?\nLa sensibilité aux dispositifs microtechnologiques varie-t-elle ?\nQuels comportements peuvent augmenter les risques liés à la microtechnologie ?\nLes facteurs environnementaux influencent-ils l'utilisation de la microtechnologie ?\nComment évaluer les facteurs de risque liés à la microtechnologie ?",
"url": "https://questionsmedicales.fr/mesh/D055616?mesh_terms=Complement+System+Proteins&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la microtechnologie aide-t-elle au diagnostic médical ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de développer des capteurs et des dispositifs d'imagerie à haute résolution."
}
},
{
"@type": "Question",
"name": "Quels dispositifs microtechnologiques sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des microcapteurs, des biosenseurs et des systèmes de microfluidique sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "La microtechnologie peut-elle détecter des maladies précocement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet une détection précoce grâce à des tests rapides et sensibles."
}
},
{
"@type": "Question",
"name": "Quels avantages la microtechnologie offre-t-elle en diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle offre précision, rapidité et réduction des coûts des tests diagnostiques."
}
},
{
"@type": "Question",
"name": "La microtechnologie est-elle utilisée pour le diagnostic génétique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet l'analyse de l'ADN à l'échelle microscopique pour des diagnostics génétiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent être détectés par microtechnologie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des anomalies biologiques ou des marqueurs de maladies peuvent être détectés."
}
},
{
"@type": "Question",
"name": "La microtechnologie peut-elle identifier des symptômes précoces ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut identifier des symptômes précoces grâce à des analyses sensibles."
}
},
{
"@type": "Question",
"name": "Quels types de symptômes sont surveillés par des dispositifs microtechnologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes liés à des maladies chroniques comme le diabète ou les maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être quantifiés par microtechnologie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dispositifs peuvent quantifier des symptômes comme la douleur ou la fatigue."
}
},
{
"@type": "Question",
"name": "La microtechnologie aide-t-elle à surveiller les symptômes en temps réel ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet une surveillance en temps réel grâce à des dispositifs portables."
}
},
{
"@type": "Question",
"name": "Comment la microtechnologie contribue-t-elle à la prévention des maladies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet le dépistage précoce et le suivi des facteurs de risque grâce à des dispositifs."
}
},
{
"@type": "Question",
"name": "Quels outils de microtechnologie sont utilisés pour la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des capteurs portables et des applications de santé pour surveiller les comportements."
}
},
{
"@type": "Question",
"name": "La microtechnologie aide-t-elle à la vaccination ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet le développement de vaccins plus efficaces et de systèmes de livraison."
}
},
{
"@type": "Question",
"name": "Quels avantages la microtechnologie offre-t-elle en prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet une approche proactive et personnalisée pour la santé des individus."
}
},
{
"@type": "Question",
"name": "La microtechnologie peut-elle aider à la gestion des épidémies ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet un suivi et une réponse rapide grâce à des outils de surveillance."
}
},
{
"@type": "Question",
"name": "Comment la microtechnologie améliore-t-elle les traitements médicaux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet des traitements ciblés et personnalisés grâce à des dispositifs miniaturisés."
}
},
{
"@type": "Question",
"name": "Quels traitements utilisent la microtechnologie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme la libération contrôlée de médicaments et la thérapie génique."
}
},
{
"@type": "Question",
"name": "La microtechnologie est-elle utilisée en chirurgie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour des techniques chirurgicales minimales et des instruments précis."
}
},
{
"@type": "Question",
"name": "Quels dispositifs microtechnologiques sont utilisés pour les traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nanorobots, des implants et des dispositifs de délivrance de médicaments."
}
},
{
"@type": "Question",
"name": "La microtechnologie peut-elle améliorer la réhabilitation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet des dispositifs de réhabilitation plus efficaces et adaptés aux patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des dispositifs microtechnologiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections, des réactions allergiques ou des défaillances des dispositifs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications liées à la microtechnologie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "En suivant des protocoles stricts de stérilisation et de maintenance des dispositifs."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes avec la microtechnologie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont rares mais peuvent survenir, nécessitant une surveillance attentive."
}
},
{
"@type": "Question",
"name": "Quels types de complications peuvent affecter les implants microtechnologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme le rejet de l'implant ou des infections locales peuvent se produire."
}
},
{
"@type": "Question",
"name": "La microtechnologie peut-elle causer des complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent apparaître à long terme, nécessitant un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à l'utilisation de la microtechnologie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'âge, les antécédents médicaux et l'état de santé général."
}
},
{
"@type": "Question",
"name": "La sensibilité aux dispositifs microtechnologiques varie-t-elle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent être plus sensibles aux matériaux utilisés dans les dispositifs."
}
},
{
"@type": "Question",
"name": "Quels comportements peuvent augmenter les risques liés à la microtechnologie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements comme le non-respect des consignes d'utilisation ou d'hygiène."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils l'utilisation de la microtechnologie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme la pollution ou l'exposition à des substances chimiques peuvent influencer."
}
},
{
"@type": "Question",
"name": "Comment évaluer les facteurs de risque liés à la microtechnologie ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des évaluations médicales et des suivis réguliers des patients utilisant ces dispositifs."
}
}
]
}
]
}
IgA nephropathy (IgAN) is one of the leading causes of end-stage renal disease (ESRD). Urine testing is a non-invasive way to track the biomarkers used for measuring renal injury. This study aimed to ...
In the discovery phase, we analysed 22 IgAN patients who were divided into three groups (IgAN 1-3) according to their estimated glomerular filtration rate (eGFR). Eight patients with primary membranou...
In the discovery phase, 747 proteins were identified in the urine of IgAN and pMN patients. There were different urine protein profiles in IgAN and pMN patients, and the bioinformatics analysis reveal...
There were abundant complement components in the urine of IgAN patients, indicating that the activation of AP and LP is involved in IgAN progression. Urinary complement proteins may be used as biomark...
The complement system has been linked to the etiopathogenesis of rheumatoid arthritis (RA). Patients with RA exhibit a dysregulated profile of lipid molecules, which has been attributed to the inflamm...
430 patients with RA were recruited. New-generation techniques were employed to conduct functional assays of the three pathways of the complement system. Serum levels of various complement components ...
After multivariable analysis, several noteworthy associations emerged between the complement system and lipid molecules. Notably, complement components most strongly linked to the lipid profile were C...
The correlation between the complement system and lipid molecule patterns is pronounced in patients with RA. This relationship is predominantly positive and primarily associated with upstream compleme...
Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (CV) events and CV mortality. Subclinical carotid atherosclerosis is independently associated with rates of incident CV...
430 patients with RA were recruited. Functional assays of the three pathways of the complement system, utilizing new-generation techniques, were assessed. Additionally, serum levels of individual comp...
After multivariable adjustment, which included traditional CV risk factors and disease-related data, C3a and C5a exhibited significant positive correlations with carotid intima media thickness. Additi...
The complement system and subclinical carotid atherosclerosis are linked in patients with RA....
Dysregulation in component 1q (C1q) levels is associated with weak placental development in preeclampsia (PE). Human immunodeficiency virus infection (HIV-1) triggers the C1q complex, resulting in ops...
Venous thromboembolism (VTE) is a common, multi-causal disease with potentially serious short- and long-term complications. In clinical practice, there is a need for improved plasma biomarker-based to...
Transplant-associated thrombotic microangiopathy remains a lethal complication of haematopoietic stem cell transplant and not all patients respond to terminal complement inhibitors. Qi et al. show tha...
The purpose of this review is to discuss the role of the complement system in the pathogenesis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) as well as the employment of co...
AAV has traditionally been considered a pauci-immune disease until recent findings demonstrated the pathogenic role of the complement system. The complement alternative pathway is crucial in AAV, and ...
The increased circulating levels of some complement components - as well as the consumption of others - in patients with AAV suggested a systemic activation of the complement system. Low C3 levels cor...
The complement (C) system is implicated in the etiopathogenesis of rheumatoid arthritis (RA). However, there is a lack of studies characterizing all three C pathways in RA patients. This study aimed t...
Neuroinflammation is emerging as an important pathological process in frontotemporal dementia (FTD), but biomarkers are lacking. We aimed to determine the value of complement proteins, which are key c...
We measured the complement proteins C1q and C3b in CSF by ELISAs in 224 presymptomatic and symptomatic GRN, C9orf72 or MAPT mutation carriers and non-carriers participating in the Genetic Frontotempor...
CSF C1q and C3b, as well as plasma C2 and C3, were elevated in symptomatic mutation carriers compared to presymptomatic carriers and non-carriers. In genetic subgroup analyses, these differences remai...
Elevated levels of CSF C1q and C3b, as well as plasma C2 and C3, demonstrate the presence of complement activation in the symptomatic stage of genetic FTD. Intriguingly, correlations with several dise...
Chronic spontaneous urticaria (CSU) is a common skin disorder characterized by daily or almost daily recurring skin edema and flare with itch and pruritus anywhere on the body for more than 6 weeks. A...